Vince A. Ackerson
CIK 1486460 · View on SEC EDGAR ↗
First SEC filing: April 12, 2010 · Latest: April 12, 2010
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 19, 2018 | TCBIO | P | 2,000 | $67.00 | $134,000 | 28,485 Direct | +7.55% | Acquired | -69.4% (price as of 2026-08-20) |
| Aug. 5, 2015 | TCBIO | S | 1,852 | $59.67 | $110,509 | 18,927 Direct | -8.91% | Disposed | -65.7% (price as of 2026-08-20) |
| Oct. 28, 2013 | TCBIO | S | 10,000 | $54.78 | $547,800 | 11,945 Direct | -45.57% | Disposed | -62.6% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 12, 2020 | TCBIO | Common Stock | Common Stock (3,294) | $0.00 | Dec. 31, 2019 | 3,294 | Disposed |
| Aug. 5, 2015 | TCBIO | Stock Appreciation Rights | Common Stock (4,470) | $22.65 | April 24, 2016 | 4,470 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 7 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| April 12, 2010 | TCBIO | Restricted Stock Units (Common Stock) [F1] | 2,032 | Direct |
| April 12, 2010 | TCBIO | Restricted Stock Units (Common Stock) [F1] | 14,000 | Direct |
| April 12, 2010 | TCBIO | Restricted Stock Units (Common Stock) [F1] | 8,189 | Direct |
| April 12, 2010 | TCBIO | Restricted Stock Units (Common Stock) [F1] | 3,072 | Direct |
| April 12, 2010 | TCBIO | Common Stock | 12,124 | Direct |
| April 12, 2010 | TCBIO | Stock Appreciation Rights→ Common Stock (4,470) | 4,470 | Direct |
| April 12, 2010 | TCBIO | Stock Options→ Common Stock (17,000) | 17,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $540,500 | — | $309,314 | — | — | — | $72,974 | $1,200,815 |
| 2018 | $506,000 | — | — | — | — | — | $71,067 | $1,471,705 |
| 2017 | $485,000 | — | — | — | — | — | $42,913 | $1,361,138 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.